A citation-based method for searching scientific literature


List of co-cited articles
8 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment.
Christian Rolfo, Judith de Vos-Geelen, Nicolas Isambert, L Rhoda Molife, Jan H M Schellens, Jacques De Grève, Luc Dirix, Peter Grundtvig-Sørensen, Guy Jerusalem, Karin Leunen,[...]. Clin Pharmacokinet 2019
11
33

Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application.
Tomi Hendrayana, André Wilmer, Verena Kurth, Ingo Gh Schmidt-Wolf, Ulrich Jaehde. Sci Pharm 2017
17
33

A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.
Naoka Murakami, Patrick Mulvaney, Melissa Danesh, Ala Abudayyeh, Adi Diab, Noha Abdel-Wahab, Maen Abdelrahim, Pascale Khairallah, Shayan Shirazian, Aleksandra Kukla,[...]. Kidney Int 2021
38
33

Cancer Mortality Among Recipients of Solid-Organ Transplantation in Ontario, Canada.
Sergio A Acuna, Kimberly A Fernandes, Corinne Daly, Lisa K Hicks, Rinku Sutradhar, S Joseph Kim, Nancy N Baxter. JAMA Oncol 2016
115
33

Pharmacokinetics and dosage adjustment in patients with renal dysfunction.
Roger K Verbeeck, Flora T Musuamba. Eur J Clin Pharmacol 2009
159
33

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
Martin Schlumberger, Makoto Tahara, Lori J Wirth, Bruce Robinson, Marcia S Brose, Rossella Elisei, Mouhammed Amir Habra, Kate Newbold, Manisha H Shah, Ana O Hoff,[...]. N Engl J Med 2015
33

Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN).
V Launay-Vacher, M Aapro, G De Castro, E Cohen, G Deray, M Dooley, B Humphreys, S Lichtman, J Rey, F Scotté,[...]. Ann Oncol 2015
48
33


Post-Transplantation Lymphoproliferative Disorders in Adults.
Daan Dierickx, Thomas M Habermann. N Engl J Med 2018
183
16

Cancer immunotherapy in a neglected population: The current use and future of T-cell-mediated checkpoint inhibitors in organ transplant patients.
Young Kwang Chae, Carlos Galvez, Jonathan F Anker, Wade T Iams, Manali Bhave. Cancer Treat Rev 2018
32
16

Chronic renal failure after transplantation of a nonrenal organ.
Akinlolu O Ojo, Philip J Held, Friedrich K Port, Robert A Wolfe, Alan B Leichtman, Eric W Young, Julie Arndorfer, Laura Christensen, Robert M Merion. N Engl J Med 2003
16

Safety of dose-reduced pemetrexed in patients with renal insufficiency.
Jordan Hill, Craig Vargo, Michael Smith, Jessica Streeter, David P Carbone. J Oncol Pharm Pract 2019
3
33

Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101.
Antonius A Miller, Daryl J Murry, Kouros Owzar, Donna R Hollis, Lionel D Lewis, Hedy L Kindler, John L Marshall, Miguel A Villalona-Calero, Martin J Edelman, Raymond J Hohl,[...]. J Clin Oncol 2007
56
16


Sorafenib-induced severe acute hepatitis in a stable liver transplant recipient.
Uta Herden, Lutz Fischer, Hansjörg Schäfer, Björn Nashan, Volker von Baehr, Martina Sterneck. Transplantation 2010
27
16

The Concise Guide to PHARMACOLOGY 2015/16: Transporters.
Stephen Ph Alexander, Eamonn Kelly, Neil Marrion, John A Peters, Helen E Benson, Elena Faccenda, Adam J Pawson, Joanna L Sharman, Christopher Southan, Jamie A Davies. Br J Pharmacol 2015
179
16



Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.
B L Lum, S Kaubisch, A M Yahanda, K M Adler, L Jew, M N Ehsan, N A Brophy, J Halsey, M P Gosland, B I Sikic. J Clin Oncol 1992
298
16

The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature.
Vivek Kumar, Atul B Shinagare, Helmut G Rennke, Sandeep Ghai, Jochen H Lorch, Patrick A Ott, Osama E Rahma. Oncologist 2020
56
16

The Concise Guide to PHARMACOLOGY 2015/16: Enzymes.
Stephen Ph Alexander, Doriano Fabbro, Eamonn Kelly, Neil Marrion, John A Peters, Helen E Benson, Elena Faccenda, Adam J Pawson, Joanna L Sharman, Christopher Southan,[...]. Br J Pharmacol 2015
517
16

CAR-T therapy in solid organ transplant recipients with treatment refractory posttransplant lymphoproliferative disorder.
Sambhavi Krishnamoorthy, Armin Ghobadi, Rowena D Santos, Joel D Schilling, Andrew F Malone, Haris Murad, Nancy L Bartlett, Tarek Alhamad. Am J Transplant 2021
16
16

Effect of CYP3A4*22, CYP3A5*3, and CYP3A Combined Genotypes on Cyclosporine, Everolimus, and Tacrolimus Pharmacokinetics in Renal Transplantation.
D J A R Moes, J J Swen, J den Hartigh, T van der Straaten, J J Homan van der Heide, J S Sanders, F J Bemelman, J W de Fijter, H J Guchelaar. CPT Pharmacometrics Syst Pharmacol 2014
59
16

Clinical determinants of calcineurin inhibitor disposition: a mechanistic review.
Thomas Vanhove, Pieter Annaert, Dirk R J Kuypers. Drug Metab Rev 2016
84
16

Treatment of post-transplant lymphoproliferative disorder (PTLD) in a heart transplant recipient with chimeric antigen receptor T-cell therapy.
Brian N Dang, James Ch'ng, Matthew Russell, Jerry C Cheng, Theodore B Moore, Juan C Alejos. Pediatr Transplant 2021
7
16

Cancer and Mortality in Solid-Organ Transplantation: Preventable or Inevitable?
William S Asch, Mark A Perazella. Am J Kidney Dis 2016
5
20

Acute Kidney Injury in Patients with Cancer.
Mitchell H Rosner, Mark A Perazella. N Engl J Med 2017
110
16

The effects of cyclosporine on the pharmacokinetics of doxorubicin in patients with small cell lung cancer.
D A Rushing, S R Raber, K A Rodvold, S C Piscitelli, G S Plank, D A Tewksbury. Cancer 1994
61
16

Immune checkpoint inhibitors in heart or lung transplantation: Early results from a registry initiative.
Anees Daud, Mandeep R Mehra, Alfonso Siu, Maryl R Johnson, Michael Perch, Marie Budev, Yousef Zakharia, Richard Cheng, Jose Nativi-Nicolau, Josef Stehlik. J Heart Lung Transplant 2020
8
16


Onco-nephrology: renal toxicities of chemotherapeutic agents.
Mark A Perazella. Clin J Am Soc Nephrol 2012
151
16

Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination.
Celine Boutros, Ahmad Tarhini, Emilie Routier, Olivier Lambotte, Francois Leroy Ladurie, Franck Carbonnel, Hassane Izzeddine, Aurelien Marabelle, Stephane Champiat, Armandine Berdelou,[...]. Nat Rev Clin Oncol 2016
594
16

Incidence and consequences of acute kidney injury in kidney transplant recipients.
Anita Mehrotra, Caren Rose, Neesh Pannu, Jagbir Gill, Marcello Tonelli, John S Gill. Am J Kidney Dis 2012
50
16

The CYP3A4*22 allele affects the predictive value of a pharmacogenetic algorithm predicting tacrolimus predose concentrations.
Laure Elens, Dennis A Hesselink, Ron H N van Schaik, Teun van Gelder. Br J Clin Pharmacol 2013
32
16

Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Review of the Literature.
Maria Giuseppa Vitale, Cinzia Baldessari, Michele Milella, Sebastiano Buti, Anna Maria Militello, Stefania Di Girolamo, Giuseppe Fornarini, Gino Perri, Umberto Basso, Marco Maruzzo,[...]. Clin Genitourin Cancer 2019
17
16

Successful Treatment of Disseminated Hepatocellular Carcinoma After Liver Transplantation With Nivolumab.
Waseem Amjad, Sandy Kotiah, Ankur Gupta, Michael Morris, Li Liu, Paul J Thuluvath. J Clin Exp Hepatol 2020
17
16

Drug interaction between dabrafenib and immunosuppressive drugs: about one case.
Matthieu Levavasseur, Sophie Darras, Laurent Mortier, Céline Goeminne, Marine Auffret, Marie Bertrand. Melanoma Res 2016
3
33

Checkpoint blockade after kidney transplantation.
Mathieu Lesouhaitier, Caroline Dudreuilh, Mathilde Tamain, Nada Kanaan, Elodie Bailly, Delphine Legoupil, Clement Deltombe, Peggy Perrin, Guillaume Manson, Cécile Vigneau,[...]. Eur J Cancer 2018
12
16

Effects of Renal Function on Crizotinib Pharmacokinetics: Dose Recommendations for Patients with ALK-Positive Non-Small Cell Lung Cancer.
Weiwei Tan, Shinji Yamazaki, Theodore R Johnson, Rong Wang, Melissa T O'Gorman, Leonid Kirkovsky, Tanya Boutros, Nicoletta M Brega, Akintunde Bello. Clin Drug Investig 2017
13
16

20-year longitudinal follow-up of measured and estimated glomerular filtration rate in kidney transplant patients.
Hans Pottel, Agnès Delay, Nicolas Maillard, Christophe Mariat, Pierre Delanaye. Clin Kidney J 2020
3
33

Safety of CAR T-cell therapy in kidney transplant recipients.
Omar Mamlouk, Ranjit Nair, Swaminathan P Iyer, Angelina Edwards, Sattva S Neelapu, Raphael E Steiner, Sherry A Adkins, Misha Hawkins, Neeraj Saini, Kartik Devashish,[...]. Blood 2021
9
16

Intratumoral Immunotherapy for Early-stage Solid Tumors.
Wan Xing Hong, Sarah Haebe, Andrew S Lee, C Benedikt Westphalen, Jeffrey A Norton, Wen Jiang, Ronald Levy. Clin Cancer Res 2020
38
16

Hospitalization Trends for Acute Kidney Injury in Kidney Transplant Recipients in the United States, 2004-2014.
Neetika Garg, Nilay Kumar, Tripti Singh, Sandesh Parajuli, Brad C Astor, Didier Mandelbrot, Arjang Djamali. Transplantation 2019
5
20


Bleomycin pulmonary toxicity: its relationship to renal dysfunction.
A G Dalgleish, R L Woods, J A Levi. Med Pediatr Oncol 1984
43
16

TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells.
Laurie Menger, Agnes Gouble, Maria A V Marzolini, Annette Pachnio, Katharina Bergerhoff, Jake Y Henry, Julianne Smith, Martin Pule, Paul Moss, Stanley R Riddell,[...]. Blood 2015
47
16

Survival after a cancer diagnosis among solid organ transplant recipients in the United States.
Monica E D'Arcy, Anna E Coghill, Charles F Lynch, Lori A Koch, Jie Li, Karen S Pawlish, Cyllene R Morris, Chandrika Rao, Eric A Engels. Cancer 2019
43
16

Differential influence of two cyclosporine formulations on everolimus pharmacokinetics: a clinically relevant pharmacokinetic interaction.
John M Kovarik, Jyoti Kalbag, Joaquim Figueiredo, Marisel Rouilly, O'Bannon Larita Frazier, Christiane Rordorf. J Clin Pharmacol 2002
62
16


Chemotherapy dosing in the setting of liver dysfunction.
John W Eklund, Steve Trifilio, Mary F Mulcahy. Oncology (Williston Park) 2005
58
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.